Outcomes and survival following neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus: Inverse propensity score weighted analysis-Reference-Cited by-同舟云学术

Outcomes and survival following neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus: Inverse propensity score weighted analysis

Published:2020-12 Issue:12 Volume:46 Page:2248-2256
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Pucher Philip H.^ORCID,Rahman Saqib A.^ORCID,Walker Robert C.,Grace Ben L.,Bateman Andrew,Iveson Tim,Jackson Andrew,Rees Charlotte,Byrne James P.,Kelly Jamie J.,Noble Fergus,Underwood Timothy J.^ORCID

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference40 articles.

1. Does the incidence of adenocarcinoma of the esophagus and gastric cardia continue to rise in the twenty-first century?-a SEER database analysis;Dubecz;J Gastrointest Surg,2013

2. Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Lordick;Ann Oncol,2016

3. Esophageal and esophagogastric junction cancers, version 1.2015;Ajani;J Natl Compr Canc Netw,2015

4. Guidelines for the management of oesophageal and gastric cancer;Allum;Gut,2011

5. Differences in esophageal cancer surgery in terms of surgical approach and extent of lymphadenectomy: findings of an international survey;van Rijswijk;Ann Surg Oncol,2019

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does neoadjuvant therapy contribute to increased risk in anastomotic leakage of esophageal cancer? A network meta‐analysis;Journal of Evidence-Based Medicine;2024-08-19

2. Risk Factors Associated With Anastomotic Stricture in Patients Undergoing Minimally Invasive Esophagectomy: Experience From a High-Volume Center;Cureus;2024-08-07

3. Application of neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy in curative surgery for esophageal cancer: A meta-analysis;World Journal of Gastrointestinal Oncology;2024-01-15

4. Are polypharmacy side effects predicted by public data still valid in real-world data?;Heliyon;2024-01

5. Peri-operative chemotherapy versus preoperative chemoradiotherapy in treatment of gastro-oesophageal junctional adenocarcinomas: A 10-year cohort study;European Journal of Surgical Oncology;2023-10